{"name":"Cytoki Pharma","slug":"cytoki-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1kNThzU1RrU09sakFCdlJaOXVVZnZhcjg2OXpIajhaMEk4N25DaF95YXo0Tk9ZakdYRl92bnBLcXZmdkZJaG1YZzVCSFVmSFRmdHpybHhTMEdVQTJQZFNDb1dXYzExZw?oc=5","date":"2025-10-30","type":"pipeline","source":"MedPage Today","summary":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC - MedPage Today","headline":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE16LXdqNmlLalVmR0taMVVpXzlrRG9rRVJvSDdoQVNyMDk2ODI2dkJVaDY0X0JibGhrWlFKMnkyWGdDelh2OEFxT25NVW1PQXRTbHN5UWxkSmxxTHZfV0VRWUxwbHB3TzkzbWtNYkUtUm1WNm80TjI3ZEpGM0hpdw?oc=5","date":"2025-07-01","type":"pipeline","source":"The Pharma Letter","summary":"Vesper Bio brings in new CEO - The Pharma Letter","headline":"Vesper Bio brings in new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBtejRTbm9QVldoa2N6NXNKc2JUREdPeWFVVUs5SGdrRWlaRHRhYkxxdWdxTWpJNlNKSnlwaFpkZFpNWEY1ZzEwd2JUUm85MllCN0JYeHQxSUhuVkhJRGZ0M1hQcjFhaDQ2THZ5NUNodUY5WVdYY21QM0ZSZ2LSAXxBVV95cUxQbXo0U25vUFZXaGtjejVzSnNiVERHT3lhVVVLOUhna0VpWkR0YWJMcXVncU1qSTZTSkp5cGhaZGRaTVhGNWcxMHdiVFJvOTJZQjdCWHh0MUlIblZISURmdDNYUHIxYWg0Nkx2eTVDaHVGOVlXWGNtUDNGUmdi?oc=5","date":"2025-07-01","type":"deal","source":"ArcticStartup","summary":"Lundbeckfonden BioCapital Partner Jacob Falck Hansen becomes CEO of Vesper Bio - ArcticStartup - ArcticStartup","headline":"Lundbeckfonden BioCapital Partner Jacob Falck Hansen becomes CEO of Vesper Bio - ArcticStartup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQU0dmV2NtVkprdkJfTEpKOVRMS3JUYXJGY1h0N3R4bnUxU2pmTGF6Q053ZUtsM0gzSkVySmF0d0VEcldVQmFfZmgyRUMxNERlUFkyTUIzbzVjYXk5VEZYeEpISUVSeHpBZUFaLXZRQS0xeEpVX2tzWVhoRmU5UUNTN1djcWU3Q0tFdUxNRUkyc3NTdnhOV0twV2lWMFRFN3VMMWxIZU8xaGprWWQ1aFB1Wk9URVo0bDVhZ0tXeVJTbWYtNHVvcjdsNjlzNHJjUEQwS3pQYmRfQ3FuVjNnZGk0ZlVzSUZhX1R5ZW5BTzJfc0xLM0N3UGVpamlzdzlCR1RwZlpPVm8ya1VFbDRKMGlpVUV4cDdLOFg1OElZbmNn?oc=5","date":"2025-05-08","type":"trial","source":"prnewswire.com","summary":"Cytoki Pharma Highlights Data Reinforcing Therapeutic Potential of Lipidated IL-22 for IBD in Digestive Diseases and Sciences Publication - prnewswire.com","headline":"Cytoki Pharma Highlights Data Reinforcing Therapeutic Potential of Lipidated IL-22 for IBD in Digestive Diseases and Sci","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNMkt4OURMMWZVbWlVUHlfZFRYQXhVUVN5bC04Tjd5V09lUHltQUNJSXNyRlhDUlJGQWhJakNZTGRSTllHWEM1dmhhNlZScEIwWFVuZVktUWhSRnRYNG9zbVNELWRoR3FNb3NfZnRaSGVvVjd5MWJISU9zdDdrX3ZXM3Y0a0dFX2JNTlF4bXNpcjBLQ012Q3BMZlF0dkdXM2sxRzZRbFYxdVBGbjBaSVpBQms5N2xBSGtlaVQ3VjB5akVMQWZSdXRwX2cwV19JTzRaZ3ZXU1BTdS12OHVZOEtEUjRPNHB0ZlBLakpZVXdVbw?oc=5","date":"2024-11-04","type":"trial","source":"prnewswire.com","summary":"Cytoki Pharma Announces First Patient Dosed in Phase 2 Study of CK-0045 in Obesity and Type 2 Diabetes - prnewswire.com","headline":"Cytoki Pharma Announces First Patient Dosed in Phase 2 Study of CK-0045 in Obesity and Type 2 Diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPaXZGcWJ1ZDZPdHFkb0NLUEpxby0xb3MxT3hnaHhlb0cwRTNDWldlUTJ6VGdncGxIYXJ0S3EwSXQ4VVY5VlprNktmYlVqOUJiaFVTcG5DMXhuVC1TaUhfazkxVnNhYXlROHdFMFdZWkxSVU1CcTRnaUd1dDRxQUF4QnBseDRlSll3djFr?oc=5","date":"2024-07-23","type":"trial","source":"Clinical Trials Arena","summary":"Cytoki Pharma’s CK-0045 reduces cardiometabolic risk factors in Phase I trial - Clinical Trials Arena","headline":"Cytoki Pharma’s CK-0045 reduces cardiometabolic risk factors in Phase I trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxONl9HcGx0N0hZa2Ntd0FSZDByOVR1cGpVLXFGRjZuTVlpMHlkT285bzJWQ3ptemhGU1laRUVEaTRCNHNpMG9LdmNDbmo3TFpSU1R5Y3JJdG9nWV9EX2x0N1A5OHVwcU1USG5GcjFDLTZ4OVVmUXhXSDhYUnZHUnFHYmhwUnM0RXZldDVLLVluWVRfWDlYc1lqcGR4cTFOQXFjckItWW5wT3lPTGtBejR5OFNOMXpvMWlEZVZaTTJsU3FtaWlCWFQ2cDR5dXgzdTRnb0h5MEhwbnoyNHlmbV9TNVZlUUFaQ05CSEg0bmYxUkpEaE5oNHpxTEF3WG1TeTQ?oc=5","date":"2024-07-23","type":"trial","source":"prnewswire.com","summary":"Cytoki Pharma Announces Positive Phase 1 Data Showing Potential of CK-0045 to Improve Cardiometabolic Risk Factors - prnewswire.com","headline":"Cytoki Pharma Announces Positive Phase 1 Data Showing Potential of CK-0045 to Improve Cardiometabolic Risk Factors","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPSWZBNFoyb1dKVFJkZUlvYjFERWZFdXh4YTBFYnNHOWJyY1BBQlMtWUQ0ZXFYWFVlRndmdjFBQmE4UUlZSlhRZ2U4aDVHU0hmWGlvSENhY1Y1WVNKdTI5VW9VVTdsdWJMS09sV28ySUNqWC1DS0FnanV6MGVSdzJyd0ZTampwM04tbWtGT08zb28zWmg4Z21kdjQ1YnlWby1PMWRtVU5yZUl5b1MwN3ktRElIWVNZSE9ZUnNzYktybVZBeFZsWndnYjhNNW9kbXp5Q0F4TnlGNjZfRjBpSkwxZVJlYlh2SmNiSHpVZGcxUG1zekhmbklUNg?oc=5","date":"2023-10-16","type":"trial","source":"BioSpace","summary":"Cytoki Pharma Presents Preclinical Data Demonstrating Weight Reduction and Improved Glucose Control with Lipidated IL-22 at ObesityWeek 2023 - BioSpace","headline":"Cytoki Pharma Presents Preclinical Data Demonstrating Weight Reduction and Improved Glucose Control with Lipidated IL-22","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}